Literature DB >> 11598113

The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different.

G Bultynck1, D Rossi, G Callewaert, L Missiaen, V Sorrentino, J B Parys, H De Smedt.   

Abstract

We compared the interaction of the FK506-binding protein (FKBP) with the type 3 ryanodine receptor (RyR3) and with the type 1 and type 3 inositol 1,4,5-trisphosphate receptor (IP(3)R1 and IP(3)R3), using a quantitative GST-FKBP12 and GST-FKBP12.6 affinity assay. We first characterized and mapped the interaction of the FKBPs with the RyR3. GST-FKBP12 as well as GST-FKBP12.6 were able to bind approximately 30% of the solubilized RyR3. The interaction was completely abolished by FK506, strengthened by the addition of Mg(2+), and weakened in the absence of Ca(2+) but was not affected by the addition of cyclic ADP-ribose. By using proteolytic mapping and site-directed mutagenesis, we pinpointed Val(2322), located in the central modulatory domain of the RyR3, as a critical residue for the interaction of RyR3 with FKBPs. Substitution of Val(2322) for leucine (as in IP(3)R1) or isoleucine (as in RyR2) decreased the binding efficiency and shifted the selectivity to FKBP12.6; substitution of Val(2322) for aspartate completely abolished the FKBP interaction. Importantly, the occurrence of the valylprolyl residue as alpha-helix breaker was an important determinant of FKBP binding. This secondary structure is conserved among the different RyR isoforms but not in the IP(3)R isoforms. A chimeric RyR3/IP(3)R1, containing the core of the FKBP12-binding site of IP(3)R1 in the RyR3 context, retained this secondary structure and was able to interact with FKBPs. In contrast, IP(3)Rs did not interact with the FKBP isoforms. This indicates that the primary sequence in combination with the local structural environment plays an important role in targeting the FKBPs to the intracellular Ca(2+)-release channels. Structural differences in the FKBP-binding site of RyRs and IP(3)Rs may contribute to the occurrence of a stable interaction between RyR isoforms and FKBPs and to the absence of such interaction with IP(3)Rs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598113     DOI: 10.1074/jbc.M106573200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

2.  Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor.

Authors:  Manjuli Rani Sharma; Loice H Jeyakumar; Sidney Fleischer; Terence Wagenknecht
Journal:  Biophys J       Date:  2005-10-07       Impact factor: 4.033

3.  Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha.

Authors:  Tie-Shan Tang; Huiping Tu; Zhengnan Wang; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

4.  Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.

Authors:  D MacMillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

5.  Proteomics reveals potential non-neuronal cholinergic receptor-effectors in endothelial cells.

Authors:  Yuan-yuan Zhang; Wei Shen; Lian-cheng Zhang; Zhi-yuan Pan; Chao-liang Long; Wen-yu Cui; Yan-fang Zhang; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

Review 6.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

7.  Ryanodine receptors.

Authors:  E Michelle Capes; Randall Loaiza; Héctor H Valdivia
Journal:  Skelet Muscle       Date:  2011-05-04       Impact factor: 4.912

8.  FK506 regulates Ca2+ release evoked by inositol 1,4,5-trisphosphate independently of FK-binding protein in endothelial cells.

Authors:  Charlotte Buckley; Calum Wilson; John G McCarron
Journal:  Br J Pharmacol       Date:  2020-01-26       Impact factor: 9.473

9.  Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax.

Authors:  Tamara Vervloessem; Haidar Akl; Thomas Tousseyn; Humbert De Smedt; Jan B Parys; Geert Bultynck
Journal:  Oncotarget       Date:  2017-12-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.